Janelle Hart

Articles

Immunotherapy Continues to Influence Perioperative Bladder Cancer Management

March 18th 2022

At the recent 15th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies, Jean Hoffman-Censits, MD, reviews advances in the use of systemic therapy to aid surgical management of bladder cancer.

Adrenocortical Carcinoma at Low/Intermediate Recurrence Risk Does Not Benefit From Postoperative Adjuvant Mitotane

Janelle Hart

February 21st 2022

Efficacy of adjuvant mitotane for patients with adrenocortical carcinoma following surgery was presented at 2022 ASCO GU.

Favorable Detection Rates Reported With 18F-rhPSMA-7.3 for Recurrence of Prostate Cancer

Janelle Hart

February 18th 2022

Data reported from the phase 3 SPOTLIGHT trial of the novel theranostic 18F-rhPSMA-7.3 at 2022 ASCO GU show “excellent image quality” for prostate cancer recurrence detection, according to expert.

Antitumor Activity Continues With Olaparib Plus Pembrolizumab Combo in mCRPC

Janelle Hart

September 15th 2021

Promising responses seen with the combination of pembrolizumab and olaparib in a cohort of patients with metastatic castration-resistant prostate cancer has led to the initiation of a phase 3 trial.